NCT03480945View on ClinicalTrials.gov

Glycemic Control and Endothelial Function in Patients With Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

July 31, 2019

Conditions
Type 2 Diabetes Mellitus
Interventions
DIAGNOSTIC_TEST

serotonin

Endothelium-dependent dilatation

Trial Locations (1)

17176

Karolinska Institutet, Karolinska University Hospital, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT03480945 - Glycemic Control and Endothelial Function in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter